Literature DB >> 27582790

Contraception in women with medical problems.

Mandish K Dhanjal1.   

Abstract

Women with medical disease have a higher incidence of maternal mortality compared with healthy women, with cardiac disease now being the most common cause of maternal death in the UK. A handful of medical conditions exist where pregnancy is not recommended due to mortality rates approaching 50%. It is imperative that such women have the most reliable methods of contraception available. Contraceptive agents may themselves affect medical disease, or may interact with medications used by such women. There may be a range of contraceptive agents suitable for each medical condition. The contraceptive selected should be tailored to suit the individual. The following points should be considered when deciding on the most appropriate contraceptive agent: efficacy, thrombotic risk (oestrogen containing contraceptives), arterial risks (oestrogen containing contraceptives), infective risk (e.g. insertion of intrauterine device [IUD]), vagal stimulation (e.g. insertion of IUD, ESSURE(®)), bleeding risks with patients on anticoagulants, interaction with concomitant drugs, effects of anaesthesia and ease of use. This review aims to cover the different contraceptive agents available and the best ones to use for certain medical illnesses.

Entities:  

Keywords:  contraception; general medicine; high-risk pregnancy

Year:  2008        PMID: 27582790      PMCID: PMC4989715          DOI: 10.1258/om.2008.080014

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  73 in total

Review 1.  FFPRHC Guidance (April 2004). The levonorgestrel-releasing intrauterine system (LNG-IUS) in contraception and reproductive health.

Authors: 
Journal:  J Fam Plann Reprod Health Care       Date:  2004-04

Review 2.  FFPRHC Guidance (April 2006). Emergency contraception.

Authors: 
Journal:  J Fam Plann Reprod Health Care       Date:  2006-04

3.  The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization.

Authors:  H B Peterson; Z Xia; J M Hughes; L S Wilcox; L R Tylor; J Trussell
Journal:  Am J Obstet Gynecol       Date:  1996-04       Impact factor: 8.661

4.  The impact of lifestyle factors on stress fractures in female Army recruits.

Authors:  J M Lappe; M R Stegman; R R Recker
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

5.  Oral progestogen-only contraceptives and cardiovascular risk: results from the Transnational Study on Oral Contraceptives and the Health of Young Women.

Authors:  L A Heinemann; A Assmann; T DoMinh; E Garbe
Journal:  Eur J Contracept Reprod Health Care       Date:  1999-06       Impact factor: 1.848

6.  Prospective study of oral contraceptives and hypertension among women in the United States.

Authors:  L Chasan-Taber; W C Willett; J E Manson; D Spiegelman; D J Hunter; G Curhan; G A Colditz; M J Stampfer
Journal:  Circulation       Date:  1996-08-01       Impact factor: 29.690

7.  Effect of Implanon and Norplant subdermal contraceptive implants on serum lipids--a randomized comparative study.

Authors:  Arijit Biswas; Osborne A C Viegas; Asim C Roy
Journal:  Contraception       Date:  2003-09       Impact factor: 3.375

8.  Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus.

Authors:  P Jungers; M Dougados; C Pélissier; F Kuttenn; F Tron; P Lesavre; J F Bach
Journal:  Arthritis Rheum       Date:  1982-06

9.  Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women.

Authors:  W O Spitzer; M A Lewis; L A Heinemann; M Thorogood; K D MacRae
Journal:  BMJ       Date:  1996-01-13

10.  Results of European post-marketing surveillance of bosentan in pulmonary hypertension.

Authors:  M Humbert; E S Segal; D G Kiely; J Carlsen; B Schwierin; M M Hoeper
Journal:  Eur Respir J       Date:  2007-05-15       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.